These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 15756524
1. Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice. Dittmann K, Toulany M, Classen J, Heinrich V, Milas L, Rodemann HP. Strahlenther Onkol; 2005 Mar; 181(3):191-6. PubMed ID: 15756524 [Abstract] [Full Text] [Related]
2. Bowman-Birk protease inhibitor activates DNA-dependent protein kinase and reduces formation of radiation-induced dicentric chromosomes. Dittmann K, Virsik-Köpp P, Mayer C, Rave-Fränk M, Rodemann HP. Int J Radiat Biol; 2003 Oct; 79(10):801-8. PubMed ID: 14630539 [Abstract] [Full Text] [Related]
3. The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport. Dittmann K, Mayer C, Kehlbach R, Rodemann HP. Radiother Oncol; 2008 Mar; 86(3):375-82. PubMed ID: 18237807 [Abstract] [Full Text] [Related]
4. The presence of wild-type TP53 is necessary for the radioprotective effect of the Bowman-Birk proteinase inhibitor in normal fibroblasts. Dittmann KH, Gueven N, Mayer C, Ohneseit P, Zell R, Begg AC, Rodemann HP. Radiat Res; 1998 Dec; 150(6):648-55. PubMed ID: 9840184 [Abstract] [Full Text] [Related]
5. Radioprotection of normal tissue to improve radiotherapy: the effect of the Bowman Birk protease inhibitor. Dittmann KH, Mayer C, Rodemann HP. Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):360-3. PubMed ID: 12871082 [Abstract] [Full Text] [Related]
6. Restoration of connexin 43 by Bowman-Birk protease inhibitor in M5076 bearing mice. Suzuki K, Yano T, Sadzuka Y, Sugiyama T, Seki T, Asano R. Oncol Rep; 2005 Jun; 13(6):1247-50. PubMed ID: 15870950 [Abstract] [Full Text] [Related]
7. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR. Nutr Cancer; 2002 Jun; 43(2):167-73. PubMed ID: 12588697 [Abstract] [Full Text] [Related]
12. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids. Foehr MW, Tomei LD, Goddard JG, Pemberton PA, Bathurst IC. Nutr Cancer; 1999 Jun; 34(2):199-205. PubMed ID: 10578488 [Abstract] [Full Text] [Related]
13. Negative growth control of osteosarcoma cell by Bowman-Birk protease inhibitor from soybean; involvement of connexin 43. Saito T, Sato H, Virgona N, Hagiwara H, Kashiwagi K, Suzuki K, Asano R, Yano T. Cancer Lett; 2007 Aug 18; 253(2):249-57. PubMed ID: 17343982 [Abstract] [Full Text] [Related]
14. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography. Billings PC, St Clair W, Owen AJ, Kennedy AR. Cancer Res; 1988 Apr 01; 48(7):1798-802. PubMed ID: 3280120 [Abstract] [Full Text] [Related]
15. Cationized Bowman-Birk protease inhibitor as a targeted cancer chemopreventive agent. Ekrami H, Kennedy AR, Witschi H, Shen WC. J Drug Target; 1993 Apr 01; 1(1):41-9. PubMed ID: 8069543 [Abstract] [Full Text] [Related]
19. The prostaglandin E1 analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. Hanson WR, Zhen W, Geng L, Hunter N, Milas L. Radiat Res; 1995 Jun 01; 142(3):281-7. PubMed ID: 7761578 [Abstract] [Full Text] [Related]